Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer
Hanshen Yang, Xiaozhen Zhang, Mengyi Lao, et al.
Cell Death and Differentiation (2022) Vol. 30, Iss. 2, pp. 560-575
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Regulatory mechanisms of PD-1/PD-L1 in cancers
Xin Lin, Kuan Kang, Pan Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 111
Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application
Hongli Gao, Jianqiao Yin, Ce Ji, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 49
Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches
Fangfang Liu, Jingyu Chen, Kai Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 41
Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options
Hongli Gao, Zhuo Xi, Jingwei Dai, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17
The E3 ubiquitin ligases regulate PD-1/PD-L1 protein levels in tumor microenvironment to improve immunotherapy
Bo Hou, Ting Chen, He Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Dual impacts of serine/glycine-free diet in enhancing antitumor immunity and promoting evasion via PD-L1 lactylation
Huan Tong, Z. X. Jiang, Linlin Song, et al.
Cell Metabolism (2024)
Open Access | Times Cited: 13
Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways
Rong Wang, Shiwei He, Jun Long, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 10
The tumour-promoting role of protein homeostasis: Implications for cancer immunotherapy
Rong Liang, Huabing Tan, Honglin Jin, et al.
Cancer Letters (2023) Vol. 573, pp. 216354-216354
Closed Access | Times Cited: 17
Bismuth Sulfide Nanoflowers Facilitated miR339 Delivery to Overcome Stemness and Radioresistance through Ubiquitin-Specific Peptidase 8 in Esophageal Cancer
Xuantong Zhou, Fene Gao, Wenyan Gao, et al.
ACS Nano (2024) Vol. 18, Iss. 29, pp. 19232-19246
Closed Access | Times Cited: 8
Stress granule-localized USP8 potentiates cGAS-mediated type I interferonopathies through deubiquitination of DDX3X
Xuejing Zhang, Lulu Han, Jinxiu Hou, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114248-114248
Open Access | Times Cited: 7
PTMs of PD-1/PD-L1 and PROTACs application for improving cancer immunotherapy
Xiaohui Ren, Lijuan Wang, Likun Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets
Zihang Hong, Furong Liu, Zhanguo Zhang
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
UCHL1 contributes to insensitivity to endocrine therapy in triple-negative breast cancer by deubiquitinating and stabilizing KLF5
Juan Li, Liang Yu, Shijie Zhou, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 5
Deubiquitinating enzymes: potential regulators of the tumor microenvironment and implications for immune evasion
Sheng‐Kai Hsu, Chon‐Kit Chou, I‐Ling Lin, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Dysregulation of deubiquitinylases: a linchpin of gastrointestinal diseases
Lorena Ferino, Michael Naumann
Trends in Molecular Medicine (2025)
Open Access
Role of Ubiquitination-driven Metabolisms in Oncogenesis and Cancer Therapy
Dongqin Yang, Can Yang, Linlin Huang, et al.
Seminars in Cancer Biology (2025)
Closed Access
Unravelling the role of ubiquitin-specific proteases in breast carcinoma: insights into tumour progression and immune microenvironment modulation
Huiyuan Yang, Tingting Sun, Zhenni Sun, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
USP19 deficiency enhances T-cell-mediated antitumor immunity by promoting PD-L1 degradation in colorectal cancer
Feng Shi, Li Gui, Yi Liu, et al.
Pharmacological Research (2025) Vol. 214, pp. 107668-107668
Open Access
Protease regulation of tumor-immune cell symbiosis
Lizhi Pang, Yu-Yun Huang, Jean Huang-Gao, et al.
Trends in cancer (2025)
Closed Access
Post-translational modifications of immune checkpoints: unlocking new potentials in cancer immunotherapy
Qiongjie Hu, Yueli Shi, Huang Wang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
PSMD11 and PSMD14 may serve as novel biomarkers for the prognosis of pancreatic ductal adenocarcinoma
Yanhui Yang, Xing Zhao, Hao Wang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Identification of USP39 as a prognostic and predictive biomarker for determining the response to immunotherapy in pancreatic cancer
Jiahui Yuan, Xu Beibei, Yongcheng Su, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Mechanistic Insights and Therapeutic Potentials of Ubiquitin‐Proteasome System in Non‐Small Cell Lung Cancer
Guangyao Zhou, Jiaxiong Tan, Zhenfa Zhang, et al.
Cell Proliferation (2025)
Open Access
The role of ferroptosis in cardio-oncology
Kai Hou, Lin Liu, Zhihui Fang, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 3, pp. 709-734
Closed Access | Times Cited: 2
Programmed Death Ligand 1 Regulatory Crosstalk with Ubiquitination and Deubiquitination: Implications in Cancer Immunotherapy
Soon-Bin Kim, Soonjae Hwang, Ji-Young Cha, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2939-2939
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top